Senior Vice President, Head Translational Sciences
Directs the global activities of all preclinical and early clinical development functions (Translational Medicine, Toxicology, Safety Pharmacology, DMPK, Animal Management). Has the final say in all matters of non-clinical safety and is the speaker for Toxicology for the entire Bayer group.
Long-lasting managerial experience in supervising departments/institutes with more than 700 employees and managing inter-disciplinary teams. Experimental experience in conducting a broad range of toxicological studies, broad experience in designing preclinical/toxicological testing strategies, broad regulatory expertise, broad expertise in toxicological risk assessment and risk management.
Chairman of the Advisory Board of the Fraunhofer Institute of Toxicology and Experimental Medicine (Hannover, Germany); Member of the Executive Council at Center of Healthcare Innovation; Member of the Advisory Committee for Pharmacologically Active Substances and Veterinary Drugs of the German Federal Institute for Risk Assessment; Member of the CAAT Advisory Board (Europe); Former member of the Scientific Committee (ECETOC)
